Lv4
650 积分 2023-01-10 加入
Finotonlimab with chemotherapy in recurrent or metastatic head and neck cancer: a randomized phase 3 trial
1天前
待确认
A multicenter real-world study comparing the clinical equivalence of trastuzumab biosimilar HLX02 and reference trastuzumab in the treatment of HER-2-positive breast cancer
10个月前
已关闭
Comparison of the efficacy and safety of 10 glucagon-like peptide-1 receptor agonists as add-on to metformin in patients with type 2 diabetes: a systematic review
10个月前
已完结
Systemic Therapy for Locally Advanced and Metastatic Non-Small Cell Lung Cancer: A Review
11个月前
已完结
Review of the Clinical Pharmacokinetics, Efficacy and Safety of Pembrolizumab
1年前
已完结
Evaluation of the pharmacokinetics and metabolism of pembrolizumab in the treatment of melanoma
1年前
已完结
Serplulimab: First Approval
1年前
已完结
Pembrolizumab: first global approval
1年前
已完结
Cost-effectiveness of afatinib and erlotinib as second-line treatments for advanced squamous cell carcinoma of the lung
1年前
已完结
Health state utilities in non-small cell lung cancer: An international study
1年前
已完结
皖公网安备34019202002308
